Physician profile
Andrew Dunn
NPI 1750709028
$7,073.62
in general payments reported to CMS, 2019-2025
5 companies · $6,837 in 2025
The $6,837 reported for 2025 was more than what 94% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $181 · 2023: $21.43 · 2024: $33.95 · 2025: $6,837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,158 · Consulting Fee: $1,240 · Travel and Lodging: $384 · Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,158.47 |
| Consulting Fee | $1,240.00 |
| Travel and Lodging | $383.51 |
| Food and Beverage | $110.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $5,611.01 | 2023-2025 | Cintec Plus Cytology, Virtuoso System For Ihc, Benchmark Ultra |
| Astrazeneca Pharmaceuticals LP | $1,240.00 | 2025 | Enhertu |
| Myriad Genetic Laboratories, INC. | $161.88 | 2022 | |
| Merck Sharp & Dohme LLC | $34.83 | 2022-2024 | Keytruda |
| Hologic Sales and Service, LLC | $25.90 | 2025 | Thinprep 2000 Processor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.